PMID- 32685478 OWN - NLM STAT- MEDLINE DCOM- 20210416 LR - 20210416 IS - 2314-6141 (Electronic) IS - 2314-6133 (Print) VI - 2020 DP - 2020 TI - Beneficial Effects of Crocin against Depression via Pituitary Adenylate Cyclase-Activating Polypeptide. PG - 3903125 LID - 10.1155/2020/3903125 [doi] LID - 3903125 AB - Depression is one of the foremost psychological illness, and the exact mechanism is unclear. Recent studies have reported that the pituitary adenylate cyclase-activating polypeptide (PACAP) signaling pathway is involved in the progression of depression. In the present study, we extracted crocin from the traditional Chinese medicine (TCM), Gardenia jasminoides Ellis, to evaluate its antidepressant effect and clarify the underlying mechanism. Here, we established a chronic unpredictable mild stress (CUMS) mouse model to assess whether crocin can improve depression-like behavior in an open field test (OFT), tail suspension test (TST), forced swimming test (FST), and sucrose preference test (SPT). A corticosterone (CORT) model of PC12 was set up to explore the antidepressant mechanism of crocin. We pretreated PC12 cells with crocin for 1 hour and then stimulated the cells with CORT for 24 hours. Cell survival was detected by Hoechst staining and MTT assay. The expression of PACAP, cyclic adenosine monophosphate (cAMP) response element binding protein (CREB), and extracellular regulated protein kinases (ERK) were analyzed by western blotting. PACAP RNAi was used to interfere with PC12 cells to downregulate the content of PACAP. The results showed that crocin (30 mg/kg) significantly reversed the decrease of body weight and elevation of serum CORT, mitigated CUMS induced depression-like behaviors of mice, and crocin (12.5 mumol/L) protected PC12 cells against CORT (200 mumol/L)-induced injury. Furthermore, crocin greatly increased the protein expression of PACAP and phosphorylation of ERK and CREB in the CORT model. PACAP RNAi cancelled the neuroprotective effect of crocin. In conclusion, these results indicated that crocin exerted an antidepressant effect via upregulating PACAP and its downstream ERK and CREB signaling pathways. CI - Copyright (c) 2020 Linyu Lu et al. FAU - Lu, Linyu AU - Lu L AUID- ORCID: 0000-0003-0520-8444 AD - School of Medicine and Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China. FAU - Wu, Die AU - Wu D AUID- ORCID: 0000-0002-8536-8095 AD - School of Medicine and Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China. FAU - Wang, Kai AU - Wang K AUID- ORCID: 0000-0001-7204-4422 AD - School of Medicine and Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China. FAU - Tang, Juanjuan AU - Tang J AUID- ORCID: 0000-0002-1397-8687 AD - School of Medicine and Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China. FAU - Chen, Gang AU - Chen G AUID- ORCID: 0000-0002-3507-1218 AD - Interdisciplinary Institute for Personalized Medicine in Brain Disorders, and Research Center for Formula and Syndromes, Jinan University, Guangzhou 510632, China. AD - Co-innovation Center of Neuroregeneration, Nantong University, Nantong, Jiangsu 226001, China. LA - eng PT - Journal Article DEP - 20200624 PL - United States TA - Biomed Res Int JT - BioMed research international JID - 101600173 RN - 0 (Cyclic AMP Response Element-Binding Protein) RN - 0 (Neuroprotective Agents) RN - 0 (Pituitary Adenylate Cyclase-Activating Polypeptide) RN - 36-88-4 (Carotenoids) RN - 877GWI46C2 (crocin) RN - EC 2.7.11.24 (Extracellular Signal-Regulated MAP Kinases) RN - W980KJ009P (Corticosterone) SB - IM MH - Animals MH - Behavior, Animal/drug effects MH - Body Weight/drug effects MH - Carotenoids/chemistry/*therapeutic use MH - Chronic Disease MH - Corticosterone/blood MH - Cyclic AMP Response Element-Binding Protein/metabolism MH - Depression/*drug therapy/*metabolism MH - Extracellular Signal-Regulated MAP Kinases/metabolism MH - Male MH - Mice, Inbred BALB C MH - Models, Biological MH - Neuroprotective Agents/metabolism MH - PC12 Cells MH - Phosphorylation/drug effects MH - Pituitary Adenylate Cyclase-Activating Polypeptide/*metabolism MH - Rats MH - Stress, Psychological/complications PMC - PMC7334775 COIS- The authors declare that they have no conflicts of interest. EDAT- 2020/07/21 06:00 MHDA- 2021/04/17 06:00 PMCR- 2020/06/24 CRDT- 2020/07/21 06:00 PHST- 2020/03/04 00:00 [received] PHST- 2020/05/17 00:00 [revised] PHST- 2020/05/26 00:00 [accepted] PHST- 2020/07/21 06:00 [entrez] PHST- 2020/07/21 06:00 [pubmed] PHST- 2021/04/17 06:00 [medline] PHST- 2020/06/24 00:00 [pmc-release] AID - 10.1155/2020/3903125 [doi] PST - epublish SO - Biomed Res Int. 2020 Jun 24;2020:3903125. doi: 10.1155/2020/3903125. eCollection 2020.